State Street’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $147M | Buy |
4,959,988
+203,322
| +4% | +$6.08M | 0.01% | 1140 |
|
|
2025
Q4 | $182M | Buy |
4,756,666
+1,538,827
| +48% | +$50M | 0.01% | 993 |
|
|
2025
Q3 | $76.9M | Sell |
3,217,839
-265,337
| -8% | -$4.99M | ﹤0.01% | 1501 |
|
|
2025
Q2 | $51.6M | Sell |
3,483,176
-163,539
| -4% | -$2.71M | ﹤0.01% | 1660 |
|
|
2025
Q1 | $65.3M | Sell |
3,646,715
-120,520
| -3% | -$2.45M | ﹤0.01% | 1504 |
|
|
2024
Q4 | $65.6M | Buy |
3,767,235
+1,030,539
| +38% | +$18.2M | ﹤0.01% | 1583 |
|
|
2024
Q3 | $38.3M | Sell |
2,736,696
-773,981
| -22% | -$8.06M | ﹤0.01% | 1839 |
|
|
2024
Q2 | $28.9M | Sell |
3,510,677
-3,098,019
| -47% | -$20.9M | ﹤0.01% | 1961 |
|
|
2024
Q1 | $51M | Buy |
6,608,696
+1,256,351
| +23% | +$10.6M | ﹤0.01% | 1720 |
|
|
2023
Q4 | $48.1M | Buy |
5,352,345
+957,088
| +22% | +$6.97M | ﹤0.01% | 1723 |
|
|
2023
Q3 | $39.3M | Sell |
4,395,257
-1,337,379
| -23% | -$18.9M | ﹤0.01% | 1777 |
|
|
2023
Q2 | $88.1M | Buy |
5,732,636
+1,364,759
| +31% | +$24.8M | ﹤0.01% | 1310 |
|
|
2023
Q1 | $98.2M | Buy |
4,367,877
+143,853
| +3% | +$3.06M | 0.01% | 1199 |
|
|
2022
Q4 | $88.8M | Buy |
4,224,024
+810,609
| +24% | +$17.2M | 0.01% | 1235 |
|
|
2022
Q3 | $84.1M | Sell |
3,413,415
-193,750
| -5% | -$5.01M | 0.01% | 1234 |
|
|
2022
Q2 | $87.4M | Buy |
3,607,165
+647,804
| +22% | +$16.3M | 0.01% | 1257 |
|
|
2022
Q1 | $76.3M | Buy |
2,959,361
+72,284
| +3% | +$1.92M | ﹤0.01% | 1485 |
|
|
2021
Q4 | $89.6M | Buy |
2,887,077
+104,754
| +4% | +$2.95M | ﹤0.01% | 1384 |
|
|
2021
Q3 | $67.5M | Sell |
2,782,323
-671,536
| -19% | -$12.3M | ﹤0.01% | 1583 |
|
|
2021
Q2 | $50.4M | Buy |
3,453,859
+1,014,332
| +42% | +$20M | ﹤0.01% | 1843 |
|
|
2021
Q1 | $60.9M | Buy |
+2,439,527
| New | +$67.4M | ﹤0.01% | 1592 |
|
|
2020
Q4 | – | Sell |
-1,920,415
| Closed | -$35.5M | – | 3907 |
|
|
2020
Q3 | $35.5M | Buy |
1,920,415
+82,309
| +4% | +$1.6M | ﹤0.01% | 1692 |
|
|
2020
Q2 | $37.5M | Buy |
1,838,106
+112,534
| +7% | +$1.79M | ﹤0.01% | 1623 |
|
|
2020
Q1 | $25.2M | Sell |
1,725,572
-11,829
| -0.7% | -$178K | ﹤0.01% | 1698 |
|
|
2019
Q4 | $24.7M | Sell |
1,737,401
-415,022
| -19% | -$5.3M | ﹤0.01% | 1997 |
|
|
2019
Q3 | $24.9M | Buy |
2,152,423
+535,168
| +33% | +$8.84M | ﹤0.01% | 1919 |
|
|
2019
Q2 | $32.5M | Buy |
1,617,255
+19,598
| +1% | +$387K | ﹤0.01% | 1765 |
|
|
2019
Q1 | $36.2M | Buy |
1,597,657
+180,708
| +13% | +$3.99M | ﹤0.01% | 1645 |
|
|
2018
Q4 | $32.1M | Sell |
1,416,949
-17,860
| -1% | -$444K | ﹤0.01% | 1645 |
|
|
2018
Q3 | $41.2M | Sell |
1,434,809
-16,603
| -1% | -$475K | ﹤0.01% | 1687 |
|
|
2018
Q2 | $39.6M | Buy |
1,451,412
+189,959
| +15% | +$5.06M | ﹤0.01% | 1641 |
|
|
2018
Q1 | $28.2M | Buy |
1,261,453
+17,430
| +1% | +$415K | ﹤0.01% | 1807 |
|
|
2017
Q4 | $26.2M | Buy |
1,244,023
+77,285
| +7% | +$1.77M | ﹤0.01% | 1865 |
|
|
2017
Q3 | $29M | Sell |
1,166,738
-21,814
| -2% | -$480K | ﹤0.01% | 1751 |
|
|
2017
Q2 | $23M | Sell |
1,188,552
-15,571
| -1% | -$282K | ﹤0.01% | 1882 |
|
|
2017
Q1 | $22.2M | Buy |
1,204,123
+2,405
| +0.2% | +$47K | ﹤0.01% | 1866 |
|
|
2016
Q4 | $22.8M | Buy |
1,201,718
+151,543
| +14% | +$3.1M | ﹤0.01% | 1807 |
|
|
2016
Q3 | $23.5M | Buy |
1,050,175
+74,752
| +8% | +$1.42M | ﹤0.01% | 1676 |
|
|
2016
Q2 | $17.4M | Sell |
975,423
-154,963
| -14% | -$2.51M | ﹤0.01% | 1853 |
|
|
2016
Q1 | $15.4M | Sell |
1,130,386
-103,221
| -8% | -$1.57M | ﹤0.01% | 1901 |
|
|
2015
Q4 | $23.8M | Sell |
1,233,607
-165,379
| -12% | -$3.3M | ﹤0.01% | 1596 |
|
|
2015
Q3 | $28.3M | Buy |
1,398,986
+82,281
| +6% | +$2.44M | ﹤0.01% | 1511 |
|
|
2015
Q2 | $43.6M | Buy |
1,316,705
+929,217
| +240% | +$25.4M | ﹤0.01% | 1355 |
|
|
2015
Q1 | $9.28M | Buy |
387,488
+95,742
| +33% | +$1.46M | ﹤0.01% | 2251 |
|
|
2014
Q4 | $3.57M | Buy |
291,746
+10,648
| +4% | +$110K | ﹤0.01% | 2749 |
|
|
2014
Q3 | $2.54M | Buy |
281,098
+22,708
| +9% | +$267K | ﹤0.01% | 2888 |
|
|
2014
Q2 | $3.04M | Buy |
258,390
+76,114
| +42% | +$1.03M | ﹤0.01% | 2860 |
|
|
2014
Q1 | $3.88M | Buy |
+182,276
| New | +$2.8M | ﹤0.01% | 2723 |
|
Other funds holding TVTX
AC
PA
VCM
NAMI
SIMG
State Street's TVTX Position: Q1 2026 in Review
State Street increased its Travere Therapeutics (TVTX) stake by 4.3% in Q1 2026, buying an estimated $6.08M and bringing the position to 4,959,988 shares worth $147M. The position accounts for 0.01% of the portfolio, ranked #1140.
State Street first reported a position in TVTX in Q1 2014 and has held it in 48 quarters since. The position peaked at $182M in Q4 2025. 260 funds tracked by Wall St. Rank hold TVTX as of Q1 2026.
- State Street held 4,959,988 shares of Travere Therapeutics worth $147M as of Q1 2026.
- State Street bought 203,322 Travere Therapeutics shares in Q1 2026, an estimated $6.08M.
- Travere Therapeutics made up 0.01% of State Street's portfolio in Q1 2026, its #1140 holding.
- State Street first reported a position in Travere Therapeutics in Q1 2014 and has held it in 48 quarters since.
- State Street's Travere Therapeutics position peaked at $182M in Q4 2025.
- 260 funds tracked by Wall St. Rank held Travere Therapeutics as of Q1 2026.
Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.